News

News 19.06.2020 Schlieren, Switzerland – June 18, 2020   InSphero AG, the pioneer of 3D cell-based assay technology, today announced that the company will relocate its corporate headquarters and research and bioproduction laboratories to a larger facility in the Bio-Technopark Schlieren-Zürich life sciences building complex, positioned in the heart of the greater Zürich biotechnology hub....

Events, Internal events
Event date: 23.06.2020 This webinar occurs several times. Please register for the date and time that works best for you. Registration: https://attendee.gotowebinar.com/rt/6328599121509174798?source=Biotechnopark Looking for more efficient ways of monitoring your bioprocesses without losing the benefits of state-of-the-art sample analyzers? Typical manual sampling procedures are time consuming, error-prone and lack a feedback mechanism to the process...

Events, Internal events
Event date: 02.07.2020 15:00 – 16:30 CET Registration Link This online event is geared towards companies developing biological drugs that are either in the early development or clinical phases. Recent global challenges have forced biotech companies, especially new and emerging companies, who are increasingly worried about handling abrupt disruptions to their supply chain, to re-think their...

Events, Internal events
Event date: 03.07.2020 NDA Group would like to invite you to an online seminar Date: 3rd July 2020 Time: 10 AM CET – 11 AM CET: presentation and general Q &A Where: Digital via Zoom Register Now: https://mailchi.mp/757a660fbb94/preparing-for-the-medical-device-regulation-virtual-seminar-572686 This seminar will discuss integrated product development for Medical Device Regulation. Our presenters will clarify the requirements applicable to...

News 08.06.2020 Zurich, Switzerland, June 4 2020 – CUTISS AG, an innovative Swiss Life Science Company aiming to provide patients that suffer from large and deep skin defects with an automatically produced, personalized skin tissue therapy, denovoSkin™, today announced it has successfully secured its series B financing round. Funds raised so far...